Craft
  • Home
  •  / Melinta Therapeutics
Melinta Therapeutics

Melinta Therapeutics

Total Funding

$519.2 M

Melinta Therapeutics Summary

Company summary

Overview
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections. Its four marketed products include Baxdela (delafloxacin), Vabomere (meropenem and vaborbactam), Orbactiv (oritavancin), and Minocin (minocycline) for injection. The Company also has an extensive pipeline of preclinical and clinical-stage products representing many important classes of antibiotics, each targeted at a different segment of the anti-infective market.
Type
Private
Founded
2000
HQ
Morristown, NJ, US | view all locations
Website
https://melinta.com/
Cybersecurity rating
Sectors

Key people

  • Sue Cammarata

    Sue Cammarata, Chief Medical Officer

  • Peter Milligan
  • Jennifer Sanfilippo

    Jennifer Sanfilippo, Senior Vice President, General Counsel

  • Kristen Allgor

    Kristen Allgor, Chief Human Resources Officer

LocationsView all

2 locations detected

  • Morristown, NJ HQ

    United States

    44 Whippany Rd Suite 280

  • New Haven, CT

    United States

    300 George Street Suite 301

Footer menu